This is a brand new award recognising a supplier that has reacted quickly to the events of 2020 and has achieved success with products related to COVID-19. It demonstrates an ability to be agile, and a contribution towards fighting the global pandemic that has kept most countries in a state of lockdown over the past year.

We are thrilled to announce that Sino Biological has been named the CiteAb Supplier Succeeding in SARS-Cov-2 Research.

From the data generated through CiteAb, we are able to gain a really clear picture of the way life science products are used around the world. We can tell which countries are investing most in research using these products, which suppliers are seeing growth or decline, which products are most successful and which areas of research are seeing growth.

This award was made based on CiteAb data gathered from the start of the COVID-19 pandemic onwards, and highlights Sino Biological as the company which has seen the most citations for COVID-19 related reagents during this time.

Dr Andrew Chalmers, founder of CiteAb, said: “Congratulations to Sino Biological for being named CiteAb Supplier Succeeding in SARS-Cov-2 Research. This is a phenomenal achievement, with data for the company demonstrating the huge impact its products have had in supporting researchers fighting the pandemic. I wish the whole team at Sino Biological many congratulations on this worthy win.”